Published June 5, 2018 | Version v1
Dataset Open

Compounds of interest identified by screening a focused library against USP5 Zf-UBD with a 19F NMR assay

  • 1. University of Toronto, Structural Genomics Consortium
  • 2. University Health Network
  • 3. University of Toronto, Department of Chemistry

Description

Screening a set of commercial compounds selected from computational docking studies against USP5 zinc finger ubiquitin binding domain (Zf-UBD) using 19F NMR spectroscopy. You can find details of preliminary 19F NMR experiments here.

Notes

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

20180605_19FNMR_cpd_screening.pdf

Files (18.4 MB)

Name Size Download all
md5:961b49e1a00a5a751cf86ce72588d158
699.4 kB Preview Download
md5:ad4a01d83905b8e77f4c57b3d65e9c93
17.3 MB Preview Download
md5:8e6763cd7742e81348331b3c16164279
449.6 kB Preview Download